List of Tables
Table 1. Global Anti-tetanus Immunoglobulin Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Anti-tetanus Immunoglobulin Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Anti-tetanus Immunoglobulin Market Competitive Situation by Manufacturers in 2024
Table 4. Global Anti-tetanus Immunoglobulin Sales (K Doses) of Key Manufacturers (2020-2025)
Table 5. Global Anti-tetanus Immunoglobulin Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Anti-tetanus Immunoglobulin Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Anti-tetanus Immunoglobulin Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Anti-tetanus Immunoglobulin Average Price (US$/Dose) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Anti-tetanus Immunoglobulin, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Anti-tetanus Immunoglobulin, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Anti-tetanus Immunoglobulin, Product Type & Application
Table 12. Global Key Manufacturers of Anti-tetanus Immunoglobulin, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Anti-tetanus Immunoglobulin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-tetanus Immunoglobulin as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Anti-tetanus Immunoglobulin Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Anti-tetanus Immunoglobulin Sales by Region (2020-2025) & (K Doses)
Table 18. Global Anti-tetanus Immunoglobulin Sales Market Share by Region (2020-2025)
Table 19. Global Anti-tetanus Immunoglobulin Sales by Region (2026-2031) & (K Doses)
Table 20. Global Anti-tetanus Immunoglobulin Sales Market Share by Region (2026-2031)
Table 21. Global Anti-tetanus Immunoglobulin Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Anti-tetanus Immunoglobulin Revenue Market Share by Region (2020-2025)
Table 23. Global Anti-tetanus Immunoglobulin Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Anti-tetanus Immunoglobulin Revenue Market Share by Region (2026-2031)
Table 25. North America Anti-tetanus Immunoglobulin Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Anti-tetanus Immunoglobulin Sales by Country (2020-2025) & (K Doses)
Table 27. North America Anti-tetanus Immunoglobulin Sales by Country (2026-2031) & (K Doses)
Table 28. North America Anti-tetanus Immunoglobulin Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Anti-tetanus Immunoglobulin Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Anti-tetanus Immunoglobulin Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Anti-tetanus Immunoglobulin Sales by Country (2020-2025) & (K Doses)
Table 32. Europe Anti-tetanus Immunoglobulin Sales by Country (2026-2031) & (K Doses)
Table 33. Europe Anti-tetanus Immunoglobulin Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Anti-tetanus Immunoglobulin Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Anti-tetanus Immunoglobulin Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Anti-tetanus Immunoglobulin Sales by Region (2020-2025) & (K Doses)
Table 37. Asia Pacific Anti-tetanus Immunoglobulin Sales by Region (2026-2031) & (K Doses)
Table 38. Asia Pacific Anti-tetanus Immunoglobulin Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Anti-tetanus Immunoglobulin Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Anti-tetanus Immunoglobulin Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Anti-tetanus Immunoglobulin Sales by Country (2020-2025) & (K Doses)
Table 42. Latin America Anti-tetanus Immunoglobulin Sales by Country (2026-2031) & (K Doses)
Table 43. Latin America Anti-tetanus Immunoglobulin Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Anti-tetanus Immunoglobulin Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Anti-tetanus Immunoglobulin Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Anti-tetanus Immunoglobulin Sales by Country (2020-2025) & (K Doses)
Table 47. Middle East and Africa Anti-tetanus Immunoglobulin Sales by Country (2026-2031) & (K Doses)
Table 48. Middle East and Africa Anti-tetanus Immunoglobulin Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Anti-tetanus Immunoglobulin Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Anti-tetanus Immunoglobulin Sales (K Doses) by Type (2020-2025)
Table 51. Global Anti-tetanus Immunoglobulin Sales (K Doses) by Type (2026-2031)
Table 52. Global Anti-tetanus Immunoglobulin Sales Market Share by Type (2020-2025)
Table 53. Global Anti-tetanus Immunoglobulin Sales Market Share by Type (2026-2031)
Table 54. Global Anti-tetanus Immunoglobulin Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Anti-tetanus Immunoglobulin Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Anti-tetanus Immunoglobulin Revenue Market Share by Type (2020-2025)
Table 57. Global Anti-tetanus Immunoglobulin Revenue Market Share by Type (2026-2031)
Table 58. Global Anti-tetanus Immunoglobulin Price (US$/Dose) by Type (2020-2025)
Table 59. Global Anti-tetanus Immunoglobulin Price (US$/Dose) by Type (2026-2031)
Table 60. Global Anti-tetanus Immunoglobulin Sales (K Doses) by Application (2020-2025)
Table 61. Global Anti-tetanus Immunoglobulin Sales (K Doses) by Application (2026-2031)
Table 62. Global Anti-tetanus Immunoglobulin Sales Market Share by Application (2020-2025)
Table 63. Global Anti-tetanus Immunoglobulin Sales Market Share by Application (2026-2031)
Table 64. Global Anti-tetanus Immunoglobulin Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Anti-tetanus Immunoglobulin Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Anti-tetanus Immunoglobulin Revenue Market Share by Application (2020-2025)
Table 67. Global Anti-tetanus Immunoglobulin Revenue Market Share by Application (2026-2031)
Table 68. Global Anti-tetanus Immunoglobulin Price (US$/Dose) by Application (2020-2025)
Table 69. Global Anti-tetanus Immunoglobulin Price (US$/Dose) by Application (2026-2031)
Table 70. SK Plasma Company Information
Table 71. SK Plasma Description and Business Overview
Table 72. SK Plasma Anti-tetanus Immunoglobulin Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 73. SK Plasma Anti-tetanus Immunoglobulin Product
Table 74. SK Plasma Recent Developments/Updates
Table 75. Baxalta Company Information
Table 76. Baxalta Description and Business Overview
Table 77. Baxalta Anti-tetanus Immunoglobulin Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 78. Baxalta Anti-tetanus Immunoglobulin Product
Table 79. Baxalta Recent Developments/Updates
Table 80. CSL Company Information
Table 81. CSL Description and Business Overview
Table 82. CSL Anti-tetanus Immunoglobulin Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 83. CSL Anti-tetanus Immunoglobulin Product
Table 84. CSL Recent Developments/Updates
Table 85. Octapharma Company Information
Table 86. Octapharma Description and Business Overview
Table 87. Octapharma Anti-tetanus Immunoglobulin Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 88. Octapharma Anti-tetanus Immunoglobulin Product
Table 89. Octapharma Recent Developments/Updates
Table 90. Grifols Company Information
Table 91. Grifols Description and Business Overview
Table 92. Grifols Anti-tetanus Immunoglobulin Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 93. Grifols Anti-tetanus Immunoglobulin Product
Table 94. Grifols Recent Developments/Updates
Table 95. LFB Company Information
Table 96. LFB Description and Business Overview
Table 97. LFB Anti-tetanus Immunoglobulin Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 98. LFB Anti-tetanus Immunoglobulin Product
Table 99. LFB Recent Developments/Updates
Table 100. Biotest Company Information
Table 101. Biotest Description and Business Overview
Table 102. Biotest Anti-tetanus Immunoglobulin Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 103. Biotest Anti-tetanus Immunoglobulin Product
Table 104. Biotest Recent Developments/Updates
Table 105. Kedrion Company Information
Table 106. Kedrion Description and Business Overview
Table 107. Kedrion Anti-tetanus Immunoglobulin Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 108. Kedrion Anti-tetanus Immunoglobulin Product
Table 109. Kedrion Recent Developments/Updates
Table 110. Hualan Biological Engineering Company Information
Table 111. Hualan Biological Engineering Description and Business Overview
Table 112. Hualan Biological Engineering Anti-tetanus Immunoglobulin Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 113. Hualan Biological Engineering Anti-tetanus Immunoglobulin Product
Table 114. Hualan Biological Engineering Recent Developments/Updates
Table 115. Sinopharm Company Information
Table 116. Sinopharm Description and Business Overview
Table 117. Sinopharm Anti-tetanus Immunoglobulin Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 118. Sinopharm Anti-tetanus Immunoglobulin Product
Table 119. Sinopharm Recent Developments/Updates
Table 120. Hualan Bio-Engineering Company Information
Table 121. Hualan Bio-Engineering Description and Business Overview
Table 122. Hualan Bio-Engineering Anti-tetanus Immunoglobulin Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 123. Hualan Bio-Engineering Anti-tetanus Immunoglobulin Product
Table 124. Hualan Bio-Engineering Recent Developments/Updates
Table 125. Nanyue Bio-Pharmaceutical Company Information
Table 126. Nanyue Bio-Pharmaceutical Description and Business Overview
Table 127. Nanyue Bio-Pharmaceutical Anti-tetanus Immunoglobulin Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 128. Nanyue Bio-Pharmaceutical Anti-tetanus Immunoglobulin Product
Table 129. Nanyue Bio-Pharmaceutical Recent Developments/Updates
Table 130. Tonglu Bio-Pharmaceutical Company Information
Table 131. Tonglu Bio-Pharmaceutical Description and Business Overview
Table 132. Tonglu Bio-Pharmaceutical Anti-tetanus Immunoglobulin Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 133. Tonglu Bio-Pharmaceutical Anti-tetanus Immunoglobulin Product
Table 134. Tonglu Bio-Pharmaceutical Recent Developments/Updates
Table 135. Sichuan Yuanda Shuyang Pharmaceutical Company Information
Table 136. Sichuan Yuanda Shuyang Pharmaceutical Description and Business Overview
Table 137. Sichuan Yuanda Shuyang Pharmaceutical Anti-tetanus Immunoglobulin Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 138. Sichuan Yuanda Shuyang Pharmaceutical Anti-tetanus Immunoglobulin Product
Table 139. Sichuan Yuanda Shuyang Pharmaceutical Recent Developments/Updates
Table 140. Wuhan Central Plain Ruide Bio-Products Company Information
Table 141. Wuhan Central Plain Ruide Bio-Products Description and Business Overview
Table 142. Wuhan Central Plain Ruide Bio-Products Anti-tetanus Immunoglobulin Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 143. Wuhan Central Plain Ruide Bio-Products Anti-tetanus Immunoglobulin Product
Table 144. Wuhan Central Plain Ruide Bio-Products Recent Developments/Updates
Table 145. Shandong Taibang Bio-Products Company Information
Table 146. Shandong Taibang Bio-Products Description and Business Overview
Table 147. Shandong Taibang Bio-Products Anti-tetanus Immunoglobulin Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 148. Shandong Taibang Bio-Products Anti-tetanus Immunoglobulin Product
Table 149. Shandong Taibang Bio-Products Recent Developments/Updates
Table 150. Guangdong Shuanglin Bio-Pharmaceutical Company Information
Table 151. Guangdong Shuanglin Bio-Pharmaceutical Description and Business Overview
Table 152. Guangdong Shuanglin Bio-Pharmaceutical Anti-tetanus Immunoglobulin Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 153. Guangdong Shuanglin Bio-Pharmaceutical Anti-tetanus Immunoglobulin Product
Table 154. Guangdong Shuanglin Bio-Pharmaceutical Recent Developments/Updates
Table 155. Chengdu Rongsheng Pharmaceutical Company Information
Table 156. Chengdu Rongsheng Pharmaceutical Description and Business Overview
Table 157. Chengdu Rongsheng Pharmaceutical Anti-tetanus Immunoglobulin Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 158. Chengdu Rongsheng Pharmaceutical Anti-tetanus Immunoglobulin Product
Table 159. Chengdu Rongsheng Pharmaceutical Recent Developments/Updates
Table 160. Shenzhen Weiguang Bio-Products Company Information
Table 161. Shenzhen Weiguang Bio-Products Description and Business Overview
Table 162. Shenzhen Weiguang Bio-Products Anti-tetanus Immunoglobulin Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 163. Shenzhen Weiguang Bio-Products Anti-tetanus Immunoglobulin Product
Table 164. Shenzhen Weiguang Bio-Products Recent Developments/Updates
Table 165. Guizhou Taibang Bio-Products Company Information
Table 166. Guizhou Taibang Bio-Products Description and Business Overview
Table 167. Guizhou Taibang Bio-Products Anti-tetanus Immunoglobulin Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 168. Guizhou Taibang Bio-Products Anti-tetanus Immunoglobulin Product
Table 169. Guizhou Taibang Bio-Products Recent Developments/Updates
Table 170. Key Raw Materials Lists
Table 171. Raw Materials Key Suppliers Lists
Table 172. Anti-tetanus Immunoglobulin Distributors List
Table 173. Anti-tetanus Immunoglobulin Customers List
Table 174. Anti-tetanus Immunoglobulin Market Trends
Table 175. Anti-tetanus Immunoglobulin Market Drivers
Table 176. Anti-tetanus Immunoglobulin Market Challenges
Table 177. Anti-tetanus Immunoglobulin Market Restraints
Table 178. Research Programs/Design for This Report
Table 179. Key Data Information from Secondary Sources
Table 180. Key Data Information from Primary Sources
Table 181. Authors List of This Report
List of Figures
Figure 1. Product Picture of Anti-tetanus Immunoglobulin
Figure 2. Global Anti-tetanus Immunoglobulin Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Anti-tetanus Immunoglobulin Market Share by Type: 2024 & 2031
Figure 4. Injection Product Picture
Figure 5. Freeze-dried Injection Product Picture
Figure 6. Global Anti-tetanus Immunoglobulin Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Anti-tetanus Immunoglobulin Market Share by Application: 2024 & 2031
Figure 8. Adults
Figure 9. Children
Figure 10. Global Anti-tetanus Immunoglobulin Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 11. Global Anti-tetanus Immunoglobulin Market Size (2020-2031) & (US$ Million)
Figure 12. Global Anti-tetanus Immunoglobulin Sales (2020-2031) & (K Doses)
Figure 13. Global Anti-tetanus Immunoglobulin Average Price (US$/Dose) & (2020-2031)
Figure 14. Anti-tetanus Immunoglobulin Report Years Considered
Figure 15. Anti-tetanus Immunoglobulin Sales Share by Manufacturers in 2024
Figure 16. Global Anti-tetanus Immunoglobulin Revenue Share by Manufacturers in 2024
Figure 17. Global 5 and 10 Largest Anti-tetanus Immunoglobulin Players: Market Share by Revenue in Anti-tetanus Immunoglobulin in 2024
Figure 18. Anti-tetanus Immunoglobulin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 19. Global Anti-tetanus Immunoglobulin Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 20. North America Anti-tetanus Immunoglobulin Sales Market Share by Country (2020-2031)
Figure 21. North America Anti-tetanus Immunoglobulin Revenue Market Share by Country (2020-2031)
Figure 22. U.S. Anti-tetanus Immunoglobulin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 23. Canada Anti-tetanus Immunoglobulin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Europe Anti-tetanus Immunoglobulin Sales Market Share by Country (2020-2031)
Figure 25. Europe Anti-tetanus Immunoglobulin Revenue Market Share by Country (2020-2031)
Figure 26. Germany Anti-tetanus Immunoglobulin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. France Anti-tetanus Immunoglobulin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. U.K. Anti-tetanus Immunoglobulin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. Italy Anti-tetanus Immunoglobulin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Russia Anti-tetanus Immunoglobulin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Asia Pacific Anti-tetanus Immunoglobulin Sales Market Share by Region (2020-2031)
Figure 32. Asia Pacific Anti-tetanus Immunoglobulin Revenue Market Share by Region (2020-2031)
Figure 33. China Anti-tetanus Immunoglobulin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Japan Anti-tetanus Immunoglobulin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. South Korea Anti-tetanus Immunoglobulin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. India Anti-tetanus Immunoglobulin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Australia Anti-tetanus Immunoglobulin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Taiwan Anti-tetanus Immunoglobulin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Indonesia Anti-tetanus Immunoglobulin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Thailand Anti-tetanus Immunoglobulin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Malaysia Anti-tetanus Immunoglobulin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Philippines Anti-tetanus Immunoglobulin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Latin America Anti-tetanus Immunoglobulin Sales Market Share by Country (2020-2031)
Figure 44. Latin America Anti-tetanus Immunoglobulin Revenue Market Share by Country (2020-2031)
Figure 45. Mexico Anti-tetanus Immunoglobulin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Brazil Anti-tetanus Immunoglobulin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Argentina Anti-tetanus Immunoglobulin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Middle East and Africa Anti-tetanus Immunoglobulin Sales Market Share by Country (2020-2031)
Figure 49. Middle East and Africa Anti-tetanus Immunoglobulin Revenue Market Share by Country (2020-2031)
Figure 50. Turkey Anti-tetanus Immunoglobulin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Saudi Arabia Anti-tetanus Immunoglobulin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. UAE Anti-tetanus Immunoglobulin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Global Sales Market Share of Anti-tetanus Immunoglobulin by Type (2020-2031)
Figure 54. Global Revenue Market Share of Anti-tetanus Immunoglobulin by Type (2020-2031)
Figure 55. Global Anti-tetanus Immunoglobulin Price (US$/Dose) by Type (2020-2031)
Figure 56. Global Sales Market Share of Anti-tetanus Immunoglobulin by Application (2020-2031)
Figure 57. Global Revenue Market Share of Anti-tetanus Immunoglobulin by Application (2020-2031)
Figure 58. Global Anti-tetanus Immunoglobulin Price (US$/Dose) by Application (2020-2031)
Figure 59. Anti-tetanus Immunoglobulin Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
